WELL · Welltower Inc.
$235.52
+1.08 (+0.46%)
At close · Aug 14
Market Cap
$162.55B
Shares
705.91M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$235.52
Open$234.14
Day$233.14–236.43
52W close$161.88–252.07
Avg vol 30d3.0M
Short int17.7M · 2.5% float · 5.9d
Short vol62%
Last earningsJul 28, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 28
Up next
Next earnings call
Oct 27, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 28, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very Low
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+14%
above
Price vs 50-day avg
+3%
above
RSI (14)
51
neutral
MACD trend
Negative
52-week position
82%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
+12%
trailing
YTD return
+27%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $229 › 200d $207 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +205 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.51% of float · ▼ -7.2% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,566 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+36%
Y/Y
EPS growth
−11%
Y/Y
Valuation
P/E 114.6
rich
Buyback
$3.0B
remaining
Balance sheet
$14.2B
net debt
Quant / Vol
risk profile
Volatility
23%
annualized · 1-yr
Max drawdown
−13%
past year
ATR
2.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 27, 2026
full year 2026
Net income attributable to common stockholders
$3.11 – $3.19
Normalized FFO attributable to common stockholders
$6.36 – $6.44
Same Store NOI growth (blended)
13.75% – 16%
Seniors Housing Operating SSNOI growth
18.5% – 21.5%
Seniors Housing Triple-net SSNOI growth
3.5% – 4.5%
Outpatient Medical SSNOI growth
2% – 3%
Stock-based compensation expense
$60M
Long-Term/Post-Acute Care SSNOI growth
2% – 3%
General and administrative expenses
$265M – $270M
next twelve months
Pro rata disposition proceeds
$1.1B
Prior guidance
period ended
· from the 8-K filed Oct 27, 2025
Normalized FFO attributable to common stockholders
· full year 2025
$5.24 – $5.30
Same Store NOI growth (blended)
· full year 2025
13.2% – 14.5%
Seniors Housing Operating SSNOI growth
· full year 2025
20.5% – 22%
Seniors Housing Triple-net SSNOI growth
· full year 2025
3.5% – 4.5%
Outpatient Medical SSNOI growth
· full year 2025
2% – 3%
Long-Term/Post-Acute Care SSNOI growth
· full year 2025
2% – 3%
General and administrative expenses
· full year 2025
$243M – $249M
Stock-based compensation expense
· full year 2025
$52M
Development funding
· full year 2025
$80M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+14%
Bullish
Price vs 50-day avg
+3%
Bullish
RSI (14)
51
Neutral
MACD trend
Negative
Bearish
52-week position
82%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $229 › 200d $207 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +205 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.51% of float · ▼ -7.2% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,566 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $162
Now $236 · 82%
Range high $252
vs 200-day avg +14%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Available liquidity non-GAAP | $9.5B | as of June 30, 2026 | — |
| Loan repayment proceeds | $155M | second quarter | — |
|
|
|||
| Net Debt to Adjusted EBITDA non-GAAP | 2.99 | as of June 30, 2026 | — |
| Net debt to consolidated enterprise value non-GAAP | 8.9% | as of June 30, 2026 | — |
| OM Portfolio pro rata proceeds from sale | $561M | second quarter | — |
|
|
|||
| OM Portfolio pro rata proceeds from sale year-to-date | $1.9B | year-to-date 2026 | — |
| Pro rata dispositions and loan repayments | $843M | second quarter | — |
|
|
|||
| Pro rata gross investments closed or under contract | $15.5B | year-to-date 2026 | — |
| Pro rata gross investments closed or under contract subsequent to quarter end | $6.1B | subsequent to quarter end | — |
| Pro rata gross investments completed | $9.4B | six months ended June 30, 2026 | — |
| Pro rata gross investments completed (including development funding) | $6.3B | second quarter | — |
| Pro rata property dispositions | $688M | second quarter | — |
|
|
|||
| SHO average occupancy growth non-GAAP | 330 | second quarter | — |
|
|
|||
| SHO portfolio organic same store revenue growth non-GAAP | 9.2% | second quarter | — |
|
|
|||
| SHO portfolio SSNOI growth non-GAAP | 20.5% | second quarter | — |
| SHO Revenue Per Occupied Room (RevPOR) growth non-GAAP | 5.2% | second quarter | — |
|
|
|||
| Total capital sourced | $4B | second quarter | — |
| Total portfolio year-over-year same store NOI growth non-GAAP | 15.5% | second quarter | — |
| available cash and restricted cash | 4.8B | As of March 31, 2026 | — |
| normalized funds from operations attributable to common stockholders (per diluted share) non-GAAP | $1.47 | first quarter | — |
| pro rata gross investments | 3.3B | first quarter | — |
| SHO portfolio SSNOI | 22.1% | first quarter | — |
| Annual normalized FFO attributable to common stockholders per diluted share non-GAAP | $5.29 | full year 2025 | — |
| Barchester acquisition price | £5.2B | fourth quarter | — |
| Barchester communities managed in RIDEA structure | 111 | fourth quarter | — |
| Barchester communities subject to long-term triple-net lease | 150 | fourth quarter | — |
| Barchester ongoing developments | 21 | fourth quarter | — |
| HC-One acquisition equity purchase price | £1.2B | fourth quarter | — |
| HC-One existing loan repaid | £660M | fourth quarter | — |
| OM Portfolio properties sold | 241 | the fourth quarter | — |
| OM Portfolio size | 18M | as of December 31, 2025 | — |
| OM Portfolio total transaction value | $7.2B | as of December 31, 2025 | — |
| Pro rata dispositions and loan payoffs completed | $7.5B | the fourth quarter | — |
| Pro rata gross investments closed or under contract subsequent to year end | $5.7B | subsequent to year end | — |
| Pro rata net investments completed | $11B | full year 2025 | — |
| Reported quarterly normalized funds from operations attributable to common stockholders of $1.45 non-GAAP | $1.45 | fourth quarter | — |
| Seniors Housing Fund I total equity commitments | $2.5B | the fourth quarter | — |
| Seniors Housing Operating portfolio properties | 1,659 | 4Q25 | — |
| Seniors Housing Operating portfolio units | 160,218 | 4Q25 | — |
| Seniors Housing Operating Same Store properties | 875 | 4Q25 | — |
| SHO portfolio same store NOI growth | 20.4% | the fourth quarter | — |
| SHO SSNOI margin expansion | 270 | the fourth quarter | — |
| Total dispositions completed for full year | $8.2B | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WELL
this stock
Welltower Inc.
|
$162.55B | +26.9% | +35.6% | 114.6 | 2.5% |
|
VTR
Ventas, Inc.
|
$45.66B | +18.3% | +18.5% | 164.8 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.34B | +29.3% | +4.5% | 59.4 | 3.5% |
|
OHI
Omega Healthcare Investors Inc
|
$13.90B | +4.9% | +13.2% | 16.3 | 4.2% |
|
AHR
American Healthcare REIT, Inc.
|
$11.83B | +15.4% | +9.1% | 78.6 | 10.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WELL | -0.6% | -3.2% | +12.4% | +0.5% | +26.9% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.0% | -7.6% | -1.4% | -3.5% | +13.0% |
Capital returns
Latest dividend
$0.85
/ share · ex Aug 12, 2026
Paid (TTM)
$3.07
/ share · 4 payouts
Dividend yield (TTM, derived)
1.30%
Buyback program
· as of Jun 30, 2026
Authorized
$3.00B
Spent (derived)
$0
Remaining
$3.00B
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
766704
CUSIP
95040Q104
13F (30d)
1466 filings
1399 filers
Visit website
Investor relations